Back to News
Market Impact: 0.22

Morgan Stanley reiterates Underweight on Progressive stock at $190

MSPGR
Analyst EstimatesAnalyst InsightsCorporate EarningsCompany FundamentalsCapital Returns (Dividends / Buybacks)
Morgan Stanley reiterates Underweight on Progressive stock at $190

Morgan Stanley reiterated an Underweight rating on Progressive with a $190 price target, below the current $198.16 share price. The firm flagged slower policies in force growth, disappointing attritional loss ratio trends, and concerns that the combined ratio may normalize higher, even as buybacks and the combined ratio continue to support the stock. Q1 2026 results were mixed: net premiums written rose 6% to $23.64 billion and EPS increased 10% to $4.80, but analysts remain divided on the outlook.

Analysis

The setup is less about one quarter and more about the slope of underwriting margin normalization. For PGR, the market is being asked to pay today for a business where premium growth is still positive but appears increasingly dependent on timing and mix rather than clean unit expansion; that usually caps multiple expansion because investors eventually discount the next 12–24 months, not the last print. The bigger second-order issue is that if policy count growth is cooling while loss costs remain sticky, buybacks become a support, not a catalyst, and support alone rarely stops a de-rating in a slowing compounding story. The competitive read-through is more interesting: disciplined pricing by Progressive can eventually force weaker auto writers to choose between share loss and margin erosion. That is bullish for the best capitalized carriers over a 12-month horizon, but near term it can still pressure the group if investors extrapolate softer growth across the personal auto space. The most vulnerable peers are those with less flexible expense structures or weaker reserve credibility, because they cannot easily defend combined ratios if frequency stays benign but severity remains inflated. The contrarian view is that consensus may be over-anchored to the company’s historical ability to self-correct quickly. If inflation moderates and rate actions keep flowing through, the current caution could prove premature; that would favor a re-rating back toward the higher end of the historical range over the next 2-3 quarters. But if the soft patch in policy count growth is real, the stock can underperform even with decent reported EPS because the market will price 2027 earnings compression earlier than the model-based consensus is willing to.